TGFB1 and chronic obstructive pulmonary disease: Subsequently, treatment with iloprost decreased collagen I production after TGF-β1 stimulation in fibroblasts from both controls (p < 0.05, Figure 3A) and COPD patients (p < 0.05, Figure 3B).